BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15075623)

  • 1. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats.
    Marco EM; Pérez-Alvarez L; Borcel E; Rubio M; Guaza C; Ambrosio E; File SE; Viveros MP
    Behav Pharmacol; 2004 Feb; 15(1):21-7. PubMed ID: 15075623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats.
    Marín S; Marco E; Biscaia M; Fernández B; Rubio M; Guaza C; Schmidhammer H; Viveros MP
    Pharmacol Biochem Behav; 2003 Feb; 74(3):649-56. PubMed ID: 12543231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour.
    Llorente-Berzal A; Fuentes S; Gagliano H; López-Gallardo M; Armario A; Viveros MP; Nadal R
    Addict Biol; 2011 Oct; 16(4):624-37. PubMed ID: 21521421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats.
    Braida D; Limonta V; Malabarba L; Zani A; Sala M
    Eur J Pharmacol; 2007 Jan; 555(2-3):156-63. PubMed ID: 17116299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
    Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
    Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.
    Rey AA; Purrio M; Viveros MP; Lutz B
    Neuropsychopharmacology; 2012 Nov; 37(12):2624-34. PubMed ID: 22850737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.
    Romero EM; Fernández B; Sagredo O; Gomez N; Urigüen L; Guaza C; De Miguel R; Ramos JA; Viveros MP
    Brain Res Dev Brain Res; 2002 Jun; 136(2):85-92. PubMed ID: 12101025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
    Vicente MA; Zangrossi H
    Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.
    Fogaça MV; Reis FM; Campos AC; Guimarães FS
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
    Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
    Strauss CV; Vicente MA; Zangrossi H
    Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
    Genn RF; Tucci S; Parikh S; File SE
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):93-9. PubMed ID: 15205871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms.
    Carey RJ; De Palma G; Damianopoulos E
    Behav Brain Res; 2002 Apr; 132(1):37-46. PubMed ID: 11853856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration.
    Cheeta S; Kenny PJ; File SE
    Eur J Neurosci; 2000 Oct; 12(10):3797-802. PubMed ID: 11029650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and Deactivation of 5-HT1 Receptor of Accumbens Shell Area does not Alter ACPA-induced Aversive Memory Deficit in Male Rat.
    Keramati-Nojedehsadat M; Oryan S; Zarrindast MR; Babapour V
    Arch Iran Med; 2017 Mar; 20(3):185-192. PubMed ID: 28287814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.
    Arévalo C; de Miguel R; Hernández-Tristán R
    Pharmacol Biochem Behav; 2001 Sep; 70(1):123-31. PubMed ID: 11566149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice.
    Balerio GN; Aso E; Maldonado R
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):504-13. PubMed ID: 16416159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.
    Hayase T; Yamamoto Y; Yamamoto K
    Behav Pharmacol; 2005 Sep; 16(5-6):395-404. PubMed ID: 16148444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.